Whether Shafinamide Tablets (Siddaco) is banned by the state and the status of domestic drug supervision and approval

Safinamide tablets (Safinamide) are currently officially on the market in China, but they are not yet included in the medical insurance reimbursement items, so patients need to purchase them at their own expense. The domestic specifications are 30pieces/ boxes, and the price per box is approximately 1,600 RMB. As an auxiliary treatment drug for Parkinson's disease, safinamide increases central dopamine levels by reversibly and selectively inhibiting monoamine oxidase B (MAO-B), thereby improving motor symptoms and drug fluctuations.

In overseas markets, safinamine tablets are also available in multiple versions. The specifications of the original drug on the market in Europe are 100 tablets/ boxes, and the price per box is about 5,000 RMB. This version has stable efficacy and rich experience in clinical use, but it is more expensive and imposes a greater financial burden on patients. Overseas original drugs usually undergo strict approval and quality control to ensure drug safety and efficacy.

In addition, safinamide generic drugs also exist overseas, especially in the Indian market. The price of a box of 100 tablets/ is about 400 RMB. Generic drugs are obviously more affordable in terms of price, and the drug ingredients are basically the same as the original drugs, which not only ensures the efficacy but also reduces the cost of medication for patients. The emergence of generic drugs provides an economically viable option for Parkinson's disease patients who require long-term medication.

Generally speaking, there are versions of safinamide available at home and abroad. Domestic patients can purchase domestic original drugs through regular pharmacies at their own expense. Overseas original drugs are expensive, while generic drugs are cheaper and have the same ingredients as the original drugs. When choosing, patients should choose appropriate drug sources and dosage forms based on their own financial status, treatment needs and doctor's guidance to ensure drug safety and therapeutic effect.

Reference materials:https://www.drugs.com/